Sign in
4

Changes in Ownership

Viking Therapeutics, Inc. Filed Acc 0001209191-24-004232

Chief Operating Officer gave up 16,958 shares (to pay taxes)

  • Chief Operating Officer acquired 31,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mancini Marianna · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-01 Grant or award : show line 1 in the form +31,667 365,466 D
2024-03-01 Shares withheld for taxes : show line 2 in the form −16,958 $85.22 $1,445,161 348,508 D
Loading xslF345X05/doc4.xml…